Frontotemporal lobar degeneration (FTLD) is distinct from Alzheimer's disease and other types of dementia due to its specific impact on the frontal and temporal lobes of the brain. Unlike Alzheimer's, which primarily affects memory, FTLD initially manifests with changes in personality, behavior, and language skills. These alterations often precede significant memory loss. FTLD encompasses several subtypes, each affecting different aspects of cognition and behavior. Unlike Alzheimer's, which is marked by the accumulation of amyloid plaques and tau protein tangles, FTLD is associated with abnormal deposits of proteins such as tau, TDP-43, or FUS. Understanding these distinctions is crucial for accurate diagnosis and treatment, as FTLD requires tailored management approaches distinct from those used for Alzheimer's disease and other forms of dementia.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States